NeuroThera Labs Inc. (NTLX : TSX-V)
Common Stock
$0.24
CAD
-0.07 (-21.31%)
Last updated: 2026-09-01
Stock Reverse Split
YesterdayThis stock executed a 1-for-14 reverse split on September 2, 2026. Historical prices have been adjusted accordingly.
Get NTLX alerts:
NTLX
NeuroThera Labs Inc.
WealthAwesomePerformance
1 Day
+0.00%
1 Week
-36.84%
1 Month
+9.09%
YTD
+41.18%
Key Statistics
Market Cap
$285.26M
52W High
$5.32
52W Low
$2.10
P/E Ratio
-
50 Day MA
$0.24
200 Day MA
$0.20
Beta
-0.20
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 9/1/2026 | $0.23 | $0.24 | $0.23 | $0.24 | $3.36 | 1,714 |
| 8/31/2026 | $0.30 | $0.30 | $0.30 | $0.30 | $4.27 | 428 |
| 8/25/2026 | $0.34 | $0.38 | $0.34 | $0.38 | $5.32 | 5,428 |
| 8/20/2026 | $0.34 | $0.34 | $0.34 | $0.34 | $4.83 | 71 |
| 8/17/2026 | $0.32 | $0.35 | $0.32 | $0.35 | $4.90 | 5,321 |
| 8/11/2026 | $0.30 | $0.33 | $0.30 | $0.33 | $4.55 | 7,285 |
| 8/7/2026 | $0.23 | $0.29 | $0.23 | $0.29 | $4.06 | 3,999 |
| 8/6/2026 | $0.24 | $0.24 | $0.24 | $0.24 | $3.43 | 1,785 |
| 7/31/2026 | $0.22 | $0.22 | $0.22 | $0.22 | $3.08 | 1,428 |
| 7/30/2026 | $0.23 | $0.24 | $0.23 | $0.24 | $3.36 | 2,321 |
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on NTLX's historical volatility
30-Day Vol
151.7%
Annualized
90-Day Vol
159.3%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$4.02
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$3.57 | C$2.11 – C$6.02 |
| 60 trading days | C$3.78 | C$1.81 – C$7.93 |
| 90 trading days | C$4.02 | C$1.62 – C$9.94 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About NeuroThera Labs Inc.
Neurothera Labs Inc. engages in the development of a portfolio of drugs based on cannabinoid molecules. The company develops programs based on tetrahydrocannabinol (THC) and/or non-psychoactive cannabidiol for the treatment of Tourette syndrome, Alzheimer's disease and agitation, autism spectrum disorder, and status epilepticus. It also focuses on e-commerce operations, which sells hemp-based products. Neurothera Labs Inc. was formerly known as Miza III Ventures Inc. The company is based in Newark, Delaware. Neurothera Labs Inc. is a subsidiary of SciSparc Ltd.
Financials
- Revenue (TTM)
- $856,000
- EBITDA
- $-2.54M
- Profit Margin
- 0.00%
- ROE (TTM)
- -399.18%
- EPS (Diluted)
- -0.93
- Book Value
- 0.00
🔄 Recent Splits
1-for-14
Sep 2, 2026
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About NTLX
Market movers
Recent TSX-V movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| CCD | Cascadero Copper Corp | $0.03 | +150.00% |
| FNR | 49 North Resources Inc | $0.03 | +50.00% |
| SPI | Canadian Spirit Resources Inc | $0.01 | +50.00% |
| TIDE-P | Intertidal Capital Corp. | $0.17 | +45.83% |
| RMD | Richmond Minerals Inc | $0.09 | +41.67% |
| TUK | Tuktu Resources Ltd. | $0.02 | +33.33% |
| BTT | Bitterroot Resources Ltd | $0.07 | +27.27% |
| DLTA | Delta Resources Ltd | $0.23 | +27.03% |
NTLX.V news timeline
4 articles covering NTLX.V, most recent first
Latest